CD59 and cancer: The Kaplan–Meier curve (Figure 3A) showed that CD59 overexpression was linked to a poor prognosis in several cancers, including CESC, GBM, HNSC, and STAD, but was associated with a favorable prognosis in patients with KIRC (Figure 3A(i–v)).